Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p195
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 195/312)
Character Range: 16702783–16711810

a psychiatrist.
C15699              P15699         CN15699          Safinamide                                                             Parkinson disease
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The treatment must be as adjunctive therapy to a levodopa-decarboxylase inhibitor combination.
C15700              P15700         CN15700          Selegiline                                                             Late stage Parkinson disease
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The treatment must be as adjunctive therapy to a levodopa-decarboxylase inhibitor combination.
C15702              P15702         CN15702          Budesonide with formoterol                                             Asthma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures - Streamlined Authority Code 15702
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have previously had frequent episodes of asthma while receiving treatment with oral corticosteroids or optimal doses of inhaled corticosteroids; OR
                                                                                                                           Patient must have experienced frequent asthma symptoms while receiving treatment with oral or inhaled corticosteroids and require single maintenance and reliever therapy; OR
                                                                                                                           Patient must have experienced frequent asthma symptoms while receiving treatment with a combination of an inhaled corticosteroid and long acting beta-2 agonist.
                                                                                                                           Patient must be aged 12 years or over.
C15704              P15704         CN15704          Esomeprazole                                                           Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have symptoms which are inadequately controlled using a standard dose proton pump inhibitor.
C15707              P15707         CN15707          Bisacodyl                                                              Anorectal congenital abnormalities
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
                                                    Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate

C15708              P15708         CN15708          Bisacodyl                                                              Constipation
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must be receiving long-term nursing care on account of age, infirmity or other condition in a hospital, nursing home or residential facility.
                                                                                                                           Patient must identify as Aboriginal or Torres Strait Islander.
C15709              P15709         CN15709          Macrogol 3350                                                          Faecal impaction
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The condition must be inadequately controlled with first line interventions such as bulk-forming agents.
C15710              P15710         CN15710          Erythromycin                                                           Severe acne                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures - Streamlined Authority Code 15710
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The condition must be one in which tetracycline therapy is inappropriate.
C15711              P15711         CN15711          Amantadine                                                             Parkinson disease
                                                                                                                           The condition must